Who owns Corvus Pharmaceuticals?
- Ticker: CRVS
- CUSIP Number: 221015100
Tip: Access positions for across all investors
Analyze quarterly positions in Corvus Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Corvus Pharmaceuticals stock
Who bought or sold Corvus Pharmaceuticals this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| OrbiMed Advisors | 6.9M | $12M | 0% | Dec 2023 |
|
| Samlyn Capital | 2.5M | $4.4M | 4% | Dec 2023 |
|
| BVF | 1.4M | $2.4M | 0% | Dec 2023 |
|
| Vanguard Group | 1.4M | $2.4M | 0% | Dec 2023 |
|
| TowerView | 437k | $769k | 28% | Dec 2023 |
|
| Two Sigma Advisers | 236k | $415k | -5% | Dec 2023 |
|
| Two Sigma Investments | 181k | $318k | -34% | Dec 2023 |
|
| Connor, Clark & Lunn Investment Management | 71k | $125k | 0% | Dec 2023 |
|
| Jackson Square Capital | 64k | $114k | 0% | Mar 2024 |
|
| Citadel Advisors | 52k | $91k | 7% | Dec 2023 |
|
| Hikari Power | 50k | $88k | 0% | Dec 2023 |
|
| Millennium Management | 41k | $72k | -62% | Dec 2023 |
|
| Jane Street | 23k | $41k | 100% | Dec 2023 |
|
| Commerce Bank N A | 20k | $35k | 0% | Dec 2023 |
|
| Charles Schwab Investment Management | 16k | $28k | 0% | Dec 2023 |
|
| Dimensional Fund Advisors | 12k | $21k | -20% | Dec 2023 |
|
| Gillespie Robinson & Grimm | 12k | $20k | 0% | Mar 2024 |
|
| Whittier Trust Co. of Nevada | 11k | $20k | 0% | Dec 2023 |
|
| Masso Torrence Wealth Management | 10k | $18k | 0% | Mar 2024 |
|
| Simplex Trading | 9.3k | $16k | -81% | Mar 2024 |
|
| UBS Group | 6.7k | $12k | 0% | Dec 2023 |
|
| Northwest Capital Management | 3.4k | $6.0k | 0% | Mar 2024 |
|
| Advisor Group Holdings | 1.2k | $2.1k | -50% | Dec 2023 |
|
| Rhumbline Advisers | 791.00 | $1.4k | 0% | Dec 2023 |
|
| Jpmorgan Chase & Co | 679.00 | $1.2k | -99% | Dec 2023 |
|
| Wells Fargo & Company | 260.00 | $457.990000 | 5% | Dec 2023 |
|
| Royal Bank of Canada | 122.00 | $0 | 100% | Dec 2023 |
|
| IFP Advisors | 24.00 | $42.000000 | 0% | Dec 2023 |
|
| Bank of America Corporation | 22.00 | $38.999400 | -99% | Dec 2023 |
|
| Parallel Advisors | 20.00 | $35.000000 | 0% | Dec 2023 |
|
| Barclays | 1.00 | $0 | -100% | Dec 2023 |
|
Who sold out of Corvus Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Marshall Wace | Sep 2023 | 198k | $289k |
| Goldman Sachs Group | Sep 2023 | 49k | $72k |
| Bank of New York Mellon | Dec 2023 | 21k | $37k |
| Virtu Financial | Sep 2023 | 17k | $25k |
| Hrt Financial | Sep 2023 | 13k | $19k |
| Two Sigma Securities | Sep 2023 | 11k | $16k |